Clinical Trials
5 trialsNCT04936308 2026-06-05
SOLSTICE
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT06641089 2026-05-18
IZAR-2
MoonLake Immunotherapeutics AG
Phase 3 Recruiting
NCT03796858 2025-02-03
COSMOS
Janssen Pharmaceutica N.V., Belgium
Phase 3 Completed
NCT03162796 2021-02-03
Discover-1
Janssen Research & Development, LLC
Phase 3 Completed
NCT01519089 2015-08-13
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Pfizer
Phase 3 Completed